|Videos|May 25, 2023
Interview with Rentschler Biopharma's Federico Pollano
Author(s)Rentschler Biopharma
KEY LEARNING OBJECTIVES
- Viewers will gain a clear understanding of Rentschler Biopharma’s US offering currently and in the near future
- Viewers will understand what sets Rentschler Biopharma apart from other CDMOs in the field
- Viewers will gain a good feel for what it is like to be a client of Rentschler Biopharma
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
4
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
5